SAN DIEGO--(BUSINESS WIRE)--Pegasus Biologics, Inc., Irvine, California based developers of unique bioimplants for soft tissue repair, announced today that their OrthADAPT™ Bioimplant has now been used in more than 1700 procedures. The announcement was made during Pegasus Biologics’ presentation at First Albany Capital’s Second Annual Orthopedics Conference in San Diego, where the company had been invited to present their technologies.
